• Department of Endocrinology, the Second People’s Hospital of Liaocheng City, Liaocheng, Shandong 252601, P. R. China;
GUO Baoqiang, Email: baoqiangg@aliyun.com
Export PDF Favorites Scan Get Citation

Objective To investigate the correlation between serum level of 25(OH)D3 and peripheral neuropathy in patients with impaired glucose tolerance. Methods A total of 108 patients with impaired glucose tolerance treated or examined between January 2012 and July 2014 were recruited in this study. According to whether peripheral neuropathy was combined, the patients were divided into neuropathy group (n=50) and non-neuropathy group (n=58). The level of 25(OH)D3 was measured and compared between the two groups, and the correlation of 25(OH)D3 with the clinical indexes of impaired glucose tolerance was analyzed. Results The level of 25(OH)D3 in the neuropathy group and non-neuropathy group was respectively (16.1±4.2) and (19.6±4.7) ng/mL with a significant difference (P<0.05). The 25(OH)D3 deficiency rate of the above two groups was respectively 80.0% and 41.38%, also with a significant difference (P<0.05). The 25(OH)D3 level had a negative correlation with body mass index (BMI) and glycosylated hemoglobin (P<0.05). Conclusions  There is a significant relationship between impaired glucose tolerance and 25(OH)D3 level. The 25(OH)D3 level has a negative correlation with BMI and glycosylated hemoglobin.

Citation: GuoBaoqiang, XuXiuli, HaoCuicui, HeDonghua. Correlation between serum level of 25(OH)D3 and peripheral neuropathy in patients with impaired glucose tolerance. West China Medical Journal, 2017, 32(2): 161-163. doi: 10.7507/1002-0179.201509033 Copy

  • Next Article

    Study on the distribution characteristics of bone metabolic markers in plateau builders and the influencing factors